Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
260
-
Total 13F shares, excl. options
-
29M
-
Shares change
-
+23.4K
-
Total reported value, excl. options
-
$3.25B
-
Value change
-
+$3.95M
-
Put/Call ratio
-
0.41
-
Number of buys
-
130
-
Number of sells
-
-114
-
Price
-
$111.83
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2019
289 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2019.
CONMED Corp - Common Stock (CNMD) has 260 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29M shares
of 30.9M outstanding shares and own 93.93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.35M shares), VANGUARD GROUP INC (3M shares), Capital Research Global Investors (2.16M shares), DIMENSIONAL FUND ADVISORS LP (1.28M shares), Champlain Investment Partners, LLC (1.13M shares), STATE STREET CORP (904K shares), MACQUARIE GROUP LTD (747K shares), PRINCIPAL FINANCIAL GROUP INC (710K shares), NORTHERN TRUST CORP (638K shares), and HealthCor Management, L.P. (536K shares).
This table shows the top 260 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.